Image

A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202

Study testing new immunotherapy for head and neck cancer patients.

Recruiting
18 years and older
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is testing new combinations of immunotherapy drugs for people with certain types of head and neck cancer. Immunotherapy helps the body's immune system fight cancer. The study is for people whose cancer has returned or spread (recurrent/metastatic) and is PD-L1 positive, meaning the cancer has a specific protein that can be targeted by these drugs.

To join, participants must have a confirmed diagnosis of this type of cancer and not have had certain previous treatments. Participants will provide a sample of their tumor for testing. If the cancer started in the oropharynx, HPV testing is needed. The study excludes people who have received similar treatments before, have certain other cancers, or have conditions like serious bleeding or autoimmune diseases.

  • Study length: Participants will be monitored for changes in their cancer and any side effects.
  • Visits needed: Regular visits for treatment and monitoring are required.
  • Risks: Potential side effects from treatment, but safety is a key focus.
Print
Study details
    Neoplasms
    Head and Neck

NCT06062420

GlaxoSmithKline

13 December 2024

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.